SAGENT PHARMACEUTICALS INC - COM (SGNT)

CUSIP: 786692103

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
22,973,556
Share change
+937,891
Total reported value
$536,701,019
Price per share
$23.37
Number of holders
92
Value change
+$18,144,049
Number of buys
49
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 786692103?
CUSIP 786692103 identifies SGNT - SAGENT PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SAGENT PHARMACEUTICALS INC - COM (SGNT) as of Q1 2014

As of 31 Mar 2014, SAGENT PHARMACEUTICALS INC - COM (SGNT) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,973,556 shares. The largest 10 holders included FRANKLIN RESOURCES INC, MORGAN STANLEY, VANGUARD GROUP INC, Sectoral Asset Management Inc, BlackRock Fund Advisors, NWQ INVESTMENT MANAGEMENT COMPANY, LLC, FMR LLC, State Street Corp, JPMORGAN CHASE & CO, and PENN CAPITAL MANAGEMENT CO INC. This page lists 92 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.